Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate cutaneous spray concentration-finding study in allergic contact dermatitis
2008-004326-16Phase 2Completed
- Sponsor
- GALENpharma GmbH
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of LAS 41002 in contact hypersensitivity (6 arms), sponsored by GALENpharma GmbH. Primary endpoint: Local eczema score. Started Jul 2008; status: completed.
02
Drugs
LAS 41002
03
Conditions
contact hypersensitivity
Beyond the preview
Go deeper on 2008-004326-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004326-16.